All posts tagged
What Happens when the Immune System Attacks Life-Saving Drugs?
More News! Shire wows with late-stage clinical results for its potential blockbuster
Roche’s Checkpoint Inhibitor Misfires in Late-Stage Trials
The Top 12 Biotech Leaders you should know in Basel
How is Biotech Transforming Pharma’s R&D Model?
Roche lands FDA Approval for the Best Multiple Sclerosis Drug Yet
On the Job Hunt? Carry off this Week’s best Careers in Biotech!
Which European Blockbusters Topped the Charts in 2016?
Can Roche & MorphoSys beat the odds in new Alzheimer’s Phase III Trials?
Hopes are up: A Second Phase III Trial for Alzheimer’s Disease
Biosimilars set to take on Oncology after a new Market Authorization
Roche doubles down in Fight against Antibiotic Resistance
Labiotech UG, All Rights Reserved -
Send this to friend